ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,909.03
-1.11%
US Tech 100
20,506.00
-0.49%
Dow Jones
42,528.36
0.00%
Brent Oil
77.215
0.20%
Bitcoin
95,079.80
-1.87%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) News

IVVD

Invivyd (IVVD)

Invivyd Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IVVD
DateTimeSourceHeadlineSymbolCompany
12/27/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
12/02/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
11/14/20249:16AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IVVDInvivyd Inc
11/14/20247:24AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
11/14/20247:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
11/14/20247:05AMGlobeNewswire Inc.Invivyd Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
11/14/20247:01AMGlobeNewswire Inc.Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the EditorNASDAQ:IVVDInvivyd Inc
11/12/20248:30AMGlobeNewswire Inc.Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRNASDAQ:IVVDInvivyd Inc
11/06/20248:01AMGlobeNewswire Inc.Invivyd to Participate in the Guggenheim Securities Healthcare Innovation ConferenceNASDAQ:IVVDInvivyd Inc
11/06/20247:01AMGlobeNewswire Inc.Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024NASDAQ:IVVDInvivyd Inc
10/29/20247:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
10/29/20247:03AMGlobeNewswire Inc.Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term ProfitabilityNASDAQ:IVVDInvivyd Inc
10/29/20247:01AMGlobeNewswire Inc.Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With No Additional Doses, In Immunocompetent ParticipantsNASDAQ:IVVDInvivyd Inc
10/16/20247:01AMGlobeNewswire Inc.Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024NASDAQ:IVVDInvivyd Inc
10/01/20247:01AMGlobeNewswire Inc.Invivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility and PEMGARDA Activity DataNASDAQ:IVVDInvivyd Inc
09/23/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
09/23/20247:01AMGlobeNewswire Inc.Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart)NASDAQ:IVVDInvivyd Inc
09/12/20247:01AMGlobeNewswire Inc.Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19NASDAQ:IVVDInvivyd Inc
09/06/20249:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
09/05/20247:01AMGlobeNewswire Inc.Invivyd to Participate in Upcoming Investor ConferencesNASDAQ:IVVDInvivyd Inc
09/04/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
09/04/20247:01AMGlobeNewswire Inc.Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™NASDAQ:IVVDInvivyd Inc
09/03/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
09/03/20247:01AMGlobeNewswire Inc.Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1, and Other Variants of InterestNASDAQ:IVVDInvivyd Inc
08/27/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
08/27/20247:01AMGlobeNewswire Inc.Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical TrialNASDAQ:IVVDInvivyd Inc
08/14/20248:25AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
08/14/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
08/14/20248:01AMGlobeNewswire Inc.Invivyd Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
08/12/20244:01PMGlobeNewswire Inc.Invivyd to Host Conference Call Discussing Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:IVVDInvivyd Inc
 Showing the most relevant articles for your search:NASDAQ:IVVD

Your Recent History

NYSE
FUBO
fuboTV
USOTC
AABB
Asia Broadband (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
FDCT
FDCTech (PK)
USOTC
XERI
Xeriant (QB)
NASDAQ
NVDA
NVIDIA
USOTC
KRTL
KRTL (PK)
USOTC
APRU
Apple Rush (PK)
USOTC
WDLF
Decentral Life (PK)
NYSE
IONQ
IonQ
USOTC
GTCH
GBT Technologies (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RNVA
Rennova Health (CE)
USOTC
AZRH
Azure (PK)
USOTC
NBRI
North Bay Resources (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads